Apollon Wealth Management LLC Has $17.03 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Apollon Wealth Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 32,509 shares of the healthcare conglomerate's stock after buying an additional 975 shares during the period. Apollon Wealth Management LLC's holdings in UnitedHealth Group were worth $17,027,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its stake in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after buying an additional 9,872 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in UnitedHealth Group by 52.1% during the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate's stock worth $1,889,000 after buying an additional 1,279 shares in the last quarter. Finally, Wellington Shields & Co. LLC lifted its holdings in shares of UnitedHealth Group by 17.6% during the fourth quarter. Wellington Shields & Co. LLC now owns 241 shares of the healthcare conglomerate's stock valued at $122,000 after acquiring an additional 36 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Down 1.3%

Shares of UnitedHealth Group stock traded down $3.73 on Thursday, reaching $288.76. 7,869,299 shares of the company were exchanged, compared to its average volume of 7,757,590. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a market capitalization of $261.95 billion, a price-to-earnings ratio of 12.09, a PEG ratio of 1.40 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average of $308.39 and a 200 day moving average of $436.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the firm posted $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.06%. UnitedHealth Group's payout ratio is presently 37.02%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $414.35.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO John F. Rex bought 17,175 shares of the company's stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.